Search Results 371-380 of 18016 for progesterone

  1. Comparison of Operation to Monitoring With/Without Endocrine Therapy For Low Risk DCIS - Mayo Clinic

    Current use of exogenous hormones (i.e., oral progesterone). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  2. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Triple negative is defined as <1% expression for estrogen receptor (ER) and progesterone receptor (PR) and negative for human epidermal growth factor ...

  3. Xinyi Tu, Ph.D. - Mayo Clinic Faculty Profiles

    Advancing triple-negative breast cancer (TNBC) therapies. TNBC is an especially aggressive cancer subtype lacking key receptors such as estrogen, progesterone ...

  4. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

    Estrogen receptor (ER), progesterone receptor (PR) positive tumors: must be refractory to hormonal therapy demonstrated by progression on at least 2 ...

  5. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    Use of oral (estrogen and progesterone), injected or implanted combined hormonal methods of contraception or placement of an intrauterine device (IUD) or ...

  6. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    ... progesterone-only contraceptive implant/injection, or have a vasectomized partner with confirmed azoospermia) throughout the entire study period and for 30 ...

  7. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

    Estrogen receptor (ER) and/or progesterone receptor (PR) positive ≥ 10%, and no human epidermal growth factor receptor 2 (HER2) amplification or overexpression ...

  8. Male breast cancer - Diagnosis and treatment - Mayo Clinic

    Your care team also considers whether your cancer cells have receptors. Tests can look for receptors for estrogen, progesterone and HER2. Results from these ...

  9. Taking a Closer Look at Menopausal Hormone Therapy and Cognitive Health - Mayo Clinic News Network

    Back in 2002, the Women's Health Initiative, a massive nationwide study of postmenopausal women, reported that hormone therapy led to an increased risk of ...

  10. Drugs and Supplements that Start with B - Mayo Clinic

    Estradiol and progesterone (oral route). Biktarvy. Also known as. Bictegravir, emtricitabine, and tenofovir alafenamide (oral route). Bildyos. Also known as.